We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guidance provides information on Acute Respiratory Infections (ARIs) in higher-risk settings.
Advice for people who have had very close contact with someone who has CCHF virus, or material contaminated with CCHF virus.
Advice for people who have come into contact with someone who has CCHF virus.
Advice for people who have come into contact with someone who has CCHF.
Guidance on symptoms of Zika virus infection and complications of the disease.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause.
Advice for people who have come into contact with someone who has the Marburg virus.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Advice for people who may have come into contact with the CCHF virus.
Advice for people who have come into direct contact with someone who has the Marburg virus disease.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).